Table 1.
Clinicopathological characteristics of 130 patients with PCa treated with radical prostatectomy (comparison between biochemical recurrence (BR) - positive versus BR-negative subgroups)
| Characteristics | Total N = 130 (%) | BR-negative* N = 88 | BR-positive** N = 42 | p value |
|---|---|---|---|---|
|
Median age, years (range) |
(130) 62.0 | 62.0 | 64.0 | 0.368 |
| (49–77) | (50.0–75.0) | (49.0–77.0) | ||
| cT stage | ||||
| T1 | 11 (8.5) | 8 (9.1) | 3 (7.1) | 0.554 |
| T2A | 14 (10.8) | 10 (11.4) | 4 (9.5) | |
| T2B | 57 (43.8) | 38 (43.2) | 19 (45.2) | |
| T3 | 37 (28.5) | 26 (29.5) | 11 (26.2) | |
| T4 | 10 (7.7) | 5 (5.7) | 5 (11.9) | |
| Tx | 1 (0.8) | 1 | 0 | |
| pT stage | ||||
| pT1 | 12 (9.2) | 9 (10.2) | 3 (7.1) | 0.606 |
| pT2 | 71 (54.6) | 47 (53.4) | 24 (57.1) | |
| pT3 | 38 (29.2) | 28 (31.8) | 10 (23.8) | |
| pT4 | 9 (6.9) | 4 (4.5) | 5 (11.9) | |
| Histological grade AJCC | ||||
| 1 | 69 (53.1) | 51 (57.9) | 18 (42.8) | 0.087 |
| 2 | 49 (37.7) | 30 (34.1) | 19 (45.2) | |
| 3 | 12 (9.2) | 7 (7.9) | 5 (11.9) | |
| Gleason Score | ||||
| ≤ 6 | 67 (51.5) | 51 (57.3) | 17 (40.5) | 0.047 |
| 7 | 50 (38.5) | 31 (34.8) | 19 (45.2) | |
| ≥ 8 | 13 (10.0) | 7 (7.9) | 6 (14.3) | |
* PSA <= 0.2 ng/mL, ** PSA > 0.2 ng/mL